- Home
- FRGE vs CMPX Comparison
FRGE vs CMPX Comparison
Compare FRGE & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- CMPX
- Stock Information
- Founded
- FRGE 2014
- CMPX 2014
- Country
- FRGE United States
- CMPX United States
- Employees
- FRGE N/A
- CMPX N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- FRGE Technology
- CMPX Health Care
- Exchange
- FRGE Nasdaq
- CMPX Nasdaq
- Market Cap
- FRGE 262.8M
- CMPX 291.8M
- IPO Year
- FRGE N/A
- CMPX N/A
- Fundamental
- Price
- FRGE $17.79
- CMPX $3.53
- Analyst Decision
- FRGE Buy
- CMPX Strong Buy
- Analyst Count
- FRGE 5
- CMPX 8
- Target Price
- FRGE $35.50
- CMPX $13.50
- AVG Volume (30 Days)
- FRGE 87.0K
- CMPX 989.7K
- Earning Date
- FRGE 11-05-2025
- CMPX 11-11-2025
- Dividend Yield
- FRGE N/A
- CMPX N/A
- EPS Growth
- FRGE N/A
- CMPX N/A
- EPS
- FRGE N/A
- CMPX N/A
- Revenue
- FRGE $90,840,000.00
- CMPX N/A
- Revenue This Year
- FRGE $32.56
- CMPX N/A
- Revenue Next Year
- FRGE $21.75
- CMPX N/A
- P/E Ratio
- FRGE N/A
- CMPX N/A
- Revenue Growth
- FRGE 14.78
- CMPX N/A
- 52 Week Low
- FRGE $6.60
- CMPX $1.27
- 52 Week High
- FRGE $24.90
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- FRGE 43.18
- CMPX 65.74
- Support Level
- FRGE $16.80
- CMPX $3.37
- Resistance Level
- FRGE $18.93
- CMPX $3.55
- Average True Range (ATR)
- FRGE 1.02
- CMPX 0.19
- MACD
- FRGE -0.22
- CMPX 0.02
- Stochastic Oscillator
- FRGE 27.81
- CMPX 81.32
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.